Business: The billion-dollar biotech

Elie Dolgin
Additional contact information
Elie Dolgin: Elie Dolgin is a science writer in Somerville, Massachusetts.

Nature, 2015, vol. 522, issue 7554, 26-28

Abstract: Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/522026a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:522:y:2015:i:7554:d:10.1038_522026a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/522026a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().